Chantix blocks the effects of nicotine by binding at alpha4beta2 neuronal nicotinic acetylcholine receptors.Chantix also provides some of nicotine's effects to ease withdrawal.
Therapeutic effects of Chantix : smoking cessation.
Oral administration (adults) : start 1 week before you stop smoking, take 0.5 mg of Chantix once daily on days 1 through 3; days 4 through 7, take 0.5 mg of Chantix b.i.d.Day 8 through the end of treatment, take 1 mg of Chantix.If you successfully stop smoking, take an additional 12-week Chantix course to help you with long-term success.
Treatment for smoking cessation lasts 12 weeks and another 12 weeks may be required.
Gradually increase the dose over the first week to a target of 1 mg of Chantix in the morning and 1 mg of Chantix in the evening.
Nausea and insomnia are common and usually temporary.Contact your health care professional if adverse effects are persistenly troubling; a dosage reduction may help in this case.
Continue trying to abstain from smoking if you have early lapses after successfully quitting.
Chantix (Varenicline) may cause blurred vision.Use caution in driving, or other activities requiring alertness.
Dosages of other drugs that you take may need adjustment when you'll stop smoking.
Set a date to quit smoking and initiate Chantix treatment 1 week prior to that date.
Don't use Chantix with nicotine patches unless directed by your prescriber.
Women : notify your health care professional if pregnancy is suspected or planned.
The clinical procedures described and recommended in this website are based on research and consultation with nursing, medical, pharmaceutical and legal authorities.To the best of our knowledge, these procedures reflect currently accepted practice; nevertheless, they can't be considered absolute and universal recommendations.Our website's purpose is to inform your about the latest news and information about medications.We are not an online pharmacy or escrow service, we are just affiliated with online pharmacies.Trademarks used within this website remain the property of the individual trademark owners and the use of such trademark is intended only to identify products by their common name.